2 unknown. .
Follow OmicsWay Corp.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy RNA sequencing, Transcriptome analysis, target drug with the score above 0,1 - Cancer | Unknown | OmicsWay Corp. | 200 | 2017-10-17 | 2021-09-14 | |
| Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer RNA sequencing, Transcriptome analysis, Trastuzumab - HER2-positive Breast Cancer | Unknown | OmicsWay Corp. | 40 | 2017-10-01 | 2021-09-14 |
Breast Neoplasms (1) · Neoplasms (1)
Gene Expression Profiling (2) · RNA-Seq (2) · Sequence Analysis, RNA (2) · Drug Delivery Systems (1) · Drug Therapy (1) · Palliative Care (1) · Trastuzumab (1)
Russia (2) · United States (2)